| Assessment Status | Rapid Review Complete |
| HTA ID | - |
| Drug | Azilsartan |
| Brand | Edarbi® |
| Indication | For the treatment of essential hypertension in adults. |
| Assessment Process | |
| Rapid review commissioned | 10/01/2012 |
| Rapid review completed | 11/01/2012 |
| Rapid review outcome | Full Pharmacoeconomic Evaluation not Recommended |